Scynexis (SCYX) Operating Expenses (2013 - 2026)
Scynexis (SCYX) posted Operating Expenses of $16.9 million for Q1 2026, up 108.48% on a QoQ basis from $8.1 million in Q4 2025, and up 91.03% year-over-year from $8.9 million in Q1 2025.
Scynexis (SCYX) Operating Expenses (2013 - 2026) Analysis & Trends
Scynexis' Operating Expenses history runs 14 years deep, the most recent figure standing at $16.9 million for Q1 2026.
- Quarterly Operating Expenses rose 91.03% year-over-year to $16.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $44.7 million (up 15.13% YoY) and the FY2025 annual result came in at $36.7 million, down 10.25% from the prior year.
- Operating Expenses was $16.9 million for Q1 2026 at Scynexis, up from $8.1 million in the prior quarter.
- Across five years, Operating Expenses topped out at $28.9 million in Q4 2023 and bottomed at $8.1 million in Q4 2025.
- A 5-year average of $14.9 million and a median of $11.8 million in 2023 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2024 — Operating Expenses plunged 68.71% — and 2026, when it soared 91.03%.
- Scynexis' Operating Expenses stood at $24.0 million in 2022, then gained by 20.23% to $28.9 million in 2023, then plunged by 68.71% to $9.0 million in 2024, then decreased by 10.02% to $8.1 million in 2025, then surged by 108.48% to $16.9 million in 2026.
- Business Quant data shows SCYX's Operating Expenses at $16.9 million in Q1 2026, $8.1 million in Q4 2025, and $8.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 455.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Scynexis | 24.46 Mn | -12.29 Mn | - | 16.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.94 Mn |
| Dec 31, 2025 | 8.13 Mn |
| Sep 30, 2025 | 8.74 Mn |
| Jun 30, 2025 | 10.93 Mn |
| Mar 31, 2025 | 8.87 Mn |
| Dec 31, 2024 | 9.03 Mn |
| Sep 30, 2024 | 10.98 Mn |
| Jun 30, 2024 | 9.97 Mn |
| Mar 31, 2024 | 10.88 Mn |
| Dec 31, 2023 | 28.86 Mn |
| Sep 30, 2023 | 11.86 Mn |
| Jun 30, 2023 | 14.94 Mn |
| Mar 31, 2023 | 11.81 Mn |
| Dec 31, 2022 | 24.01 Mn |
| Sep 30, 2022 | 23.36 Mn |
| Jun 30, 2022 | 23.06 Mn |
| Mar 31, 2022 | 20.43 Mn |
| Dec 31, 2021 | 22.89 Mn |
| Sep 30, 2021 | 19.96 Mn |
| Jun 30, 2021 | 17.51 Mn |